Jonathan Lewis

Jonathan J. Lewis, M.D., Ph.D., is a surgeon, biomedical researcher and entrepreneur. He was trained in surgery in South Africa, Britain, and the United States, and is a fellow of both the Royal College of Surgeons and the American College of Surgeons. Dr. Lewis was awarded an MB.B.Ch. from University of the Witwatersrand School of Medicine, and his Ph.D. in Molecular Biology from Witwatersrand and Yale School of Medicine. He completed his Surgical Residency at Charlotte Maxeke Johannesburg Academic Hospital and at Yale-New Haven Hospital. Lewis was a Professor of Surgery and Medicine Memorial Sloan-Kettering Cancer Center, before working in the biotechnology industry, first as chief medical officer of RubyConn, then as chairman and chief executive officer of ZIOPHARM Oncology, Inc. He is currently chairman of the Molecular Ninja Group and chief executive officer of Samus Therapeutics.